APOB and peripheral arterial disease: In the MR-BMA analysis for lipoprotein subfractions, XS.VLDL.P was prioritized as the primary ApoB-containing risk factor for PAD (marginal inclusion probability, 0.91; P=2.3×10−4; Table 2 and Table IX in the Data Supplement).